Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 10%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 10% ownership in IMMUNIC, INC. Common Stock, $0.0001 par value (IMUX) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 6.4% | 6,268,162 | 0 | 6,268,162 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 6.4% | 6,268,162 | 0 | 6,268,162 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.2% | 3,027,105 | 0 | 3,027,105 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.2% | 3,027,105 | 0 | 3,027,105 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.3% | 315,231 | 0 | 315,231 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.3% | 315,231 | 0 | 315,231 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 9.5% | 9,295,267 | 0 | 9,295,267 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 10% | 9,785,178 | 0 | 9,785,178 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 10% | 9,785,178 | 0 | 9,785,178 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 10% | 9,785,178 | 0 | 9,785,178 | /s/ Mark N. Lampert | Mark N. Lampert |